ARS Pharmaceuticals (SPRY) Prepaid Assets (2020 - 2026)

ARS Pharmaceuticals has disclosed Prepaid Assets across 7 years of filings, most recently posting $6.8 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $6.8 million, down 18.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.8 million (down 18.62% YoY), and the FY2025 annual result was $6.2 million, down 10.05% from the prior year.
• Prepaid Assets came in at $6.8 million for Q1 2026 at ARS Pharmaceuticals, up from $6.2 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $8.3 million in Q1 2025 to a low of $137000.0 in Q3 2024.
• The 5-year median for Prepaid Assets is $1.3 million (2025), against an average of $3.2 million.
• Across the five-year window, Prepaid Assets slumped 94.66% in 2024 and surged 1112.35% in 2025, its largest moves.
• ARS Pharmaceuticals' Prepaid Assets stood at $771000.0 in 2022, then jumped by 45.78% to $1.1 million in 2023, then soared by 512.63% to $6.9 million in 2024, then fell by 10.05% to $6.2 million in 2025, then climbed by 9.59% to $6.8 million in 2026.
• The last three Prepaid Assets figures came in at $6.8 million (Q1 2026), $6.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.